Microencapsulation of islets of Langerhans: Impact of cellular overgrowth. Mini review based on a doctoral thesis

Upsala Journal of Medical Sciences

Volumn 106, Issue 3, 2001, Pages 161-174

  King, Aileen ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL DIVISION; FIBROBLAST; HUMAN; MACROPHAGE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; REVIEW;

ANIMALS; CELL DIVISION; FIBROBLASTS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MACROPHAGES;

EID: 0035553634     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-140     Document Type: Review

References (104)

1. Andersson, A., Borg, H., Hallberg, A., Hellerström, C., Sandler, S. & Schnell, A.: Long-term effects of cyclosporin A on cultured mouse pancreatic islets: Diabetologia 27 Suppl:66-69, 1984.
2. Andersson, A. K., Flodström, M. & Sandler, S.: Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase: Biochem Biophys Res Commun 281:396-403, 2001.
3. Babensee, J. E., Anderson, J. M., McIntire, L. V. & Mikos, A. G.: Host response to tissue engineered devices: Adv Drug Deliv Rev 33:111-139, 1998.
4. Bach, J. F.: Insulin-dependent diabetes mellitus as an autoimmune disease: Endocr Rev 15:516-542, 1994.
5. Ballinger, W. & Lacy, P. E.: Transplantation of intact pancreatic islets in rats.: Surgery 72:175-186, 1972.
6. Brendel, M., Hering, B., Schultz, A. & Bretzel, R. G.: International islet transplant registry.: Islet transplantation registry Newsletter 8:1:3-18, 2001.
7. Chaikof, E.: Engineering and material considerations in islet cell transplantation: Annu Rev Biomed Eng 1:103-127, 1999.
8. Chang, T. M.: Semipermeable microcapsules: Science 146:524-525, 1964.
9. Cheng, W. T., Chen, B. C., Chiou, S. T. & Chen, C. M.: Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swine: Hum Gene Ther 9:1995-2003, 1998.
10. Chicheportiche, D. & Reach, G.: In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules: Diabetologia 31:54-57, 1988.
11. Clancy, R. M., Amin, A. R. & Abramson, S. B.: The role of nitric oxide in inflammation and immunity: Arthritis Rheum 41:1141-1151, 1998.
12. Clayton, H. A., James, R. F. & London, N. J.: Islet microencapsulation: a review: Acta Diabetol 30:181-189, 1993.
13. Clayton, H. A., London, N. J., Bell, P. R. & James, R. F.: The transplantation of encapsulated islets of Langerhans into the peritoneal cavity of the biobreeding rat: Transplantation 54:558-560, 1992.
14. Clayton, H. A., London, N. J., Colloby, P. S., Bell, P. R. & James, R. F.: A study of the effect of capsule composition on the viability of cultured alginate/poly-l-lysine-encapsulated rat islets: Diabetes Res 14:127-132, 1990.
15. Clayton, H., London, N., Colloby, P. & Bell, P.: The effect of capsule composition on the biocompatibility of alginate-poly-lysine capsules.: J Microencapsulation 8:221-233, 1991.
16. Cole, D. R., Waterfall, M., McIntyre, M. & Baird, J. D.: Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure: Diabetologia 35:231-237, 1992.
17. Colton, C. K.: Implantable biohybrid artificial organs: Cell Transplant 4:415-436, 1995.
18. Colton, C. K. & Avgoustiniatos, E. S.: Bioengineering in development of the hybrid artificial pancreas: J Biomech Eng 113:152-170, 1991.
19. Costa Rosa, L. F., Safi, D. A., Cury, Y. & Curi, R.: The effect of insulin on macrophage metabolism and function: Cell Biochem Funct 14:33-42, 1996.
20. Darquy, S., Chicheportiche, D., Capron, F., Boitard, C. & Reach, G.: Comparative study of microencapsulated rat islets implanted in different diabetic models in mice: Horm Metab Res Suppl 25:209-213, 1990.
21. De Vos, P., De Haan, B., Pater, J. & Van Schilfgaarde, R.: Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts: Transplantation 62:893-899, 1996.
22. De Vos, P., De Haan, B. & Van Schilfgaarde, R.: Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules: Biomaterials 18:273-278, 1997.
23. De Vos, P., Van Straaten, J. F., Nieuwenhuizen, A. G., de Groot, M., Ploeg, R. J., De Haan, B. J. & Van Schilfgaarde, R.: Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?: Diabetes 48:1381-1388, 1999.
24. De Vos, P., Wolters, G. H., Fritschy, W. M. & Van Schilfgaarde, R.: Obstacles in the application of microen-capsulation in islet transplantation: Int J Artif Organs 16:205-212, 1993.
25. De Vos, P., Wolters, G. H. & Van Schilfgaarde, R.: Possible relationship between fibrotic overgrowth of alginate- polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity: Transplant Proc 26:782-783, 1994.
26. Delaney, C. A. & Eizirik, D. L.: Intracellular targets for nitric oxide toxicity to pancreatic beta- cells: Braz J Med Biol Res 29:569-579, 1996.
27. Duvivier-Kali, V. F., Orner, A., Parent, R. J., O'Neil, J. J. & Weir, G. C.: Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane: Diabetes 50:1698-1705, 2001.
28. Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D.A., Pipeleers, D.G., Bendtzen, K. & Hellerstrom, C.: Cytokines suppress human islet function irrespective of their effects on nitric oxide generation: J Clin Invest 93:1968-1974, 1994.
29. Fritschy, W. M., De Vos, P., Groen, H., Klatter, F. A., Pasma, A., Wolters, G. H. & Van Schilfgaarde, R.: The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats: Transpl Int 7:264-271, 1994.
30. Fritschy, W. M., Wolters, G. H. & Van Schilfgaarde, R.: Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets: Diabetes 40:37-43, 1991.
31. Gray, D.: Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence.: Brit Med Bull 53:777, 1997.
32. Gummert, J. F., Ikonen, T. & Morris, R. E.: Newer immunosuppressive drugs: a review: J Am Soc Nephrol 10:1366-1380, 1999.
33. Hanker, J. S. & Giammara, B. L.: Biomaterials and biomedical devices: Science 242:885-892, 1988.
34. Hasse, C., Bohrer, T., Barth, P., Stinner, B., Cohen, R., Cramer, H., Zimmermann, U. & Rothmund, M.: Parathyroid xenotransplantation without immunosuppression in experimental hypoparathyroidism: long-term In vivo function following microencapsulation with a clinically suitable alginate: World J Surg 24:1361-1366, 2000.
35. Heel, K. A. & Hall, J. C.: Peritoneal defences and peritoneum-associated lymphoid tissue: Br J Surg 83:1031-1036, 1996.
36. Hickey, M. J., Sharkey, K. A., Sihota, E. G., Reinhardt, P. H., MacMicking, J. D., Nathan, C. & Kubes, P.: Inducible nitric oxide synthase-deficient mice have enhanced leukocyte- endothelium interactions in endotoxemia: FASEB J 11:955-964, 1997.
37. Horcher, A., Zekorn, T., Siebers, U., Klock, G., Frank, H., Houben, R., Bretzel, R. G., Zimmermann, U. & Federlin, K.: Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules: Transplant Proc 26:784-786, 1994.
38. Hortelano, G., Xu, N., Vandenberg, A., Solera, J., Chang, P. L. & Ofosu, F. A.: Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules: Hum Gene Ther 10:1281-1288, 1999.
39. Hunt, J. A., McLaughlin, P .J. & Flanagan, B. F.: Techniques to investigate cellular and molecular interactions in the host response to implanted biomaterials: Biomaterials 18:1449-1459, 1997.
40. Jansson, E.: The regulation of pancreatic islet blood flow: Diabetes Metab Rev 10:407-416, 1994.
41. Jindal, R. M.: Posttransplant diabetes mellitus-a review: Transplantation 58:1289-1298, 1994.
42. Jones, E. Y., Stuart, D. I. & Walker, N. P.: Structure of tumour necrosis factor: Nature 338:225-228, 1989.
43. Kaur, S., Cortiella, J. & Vacanti, C. A.: Identifying a site for maximum delivery of oxygen to transplanted cells: Tissue Eng 6:229-232, 2000.
44. King, A., Andersson, A. & Sandler, S.: Cylokine-induced functional suppression of microencapsulated rat pancreatic islets in vitro: Transplantation 70:380-383, 2000.
45. King, A., Sandler, S. & Andersson, A.: The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules: J Biomed Mater Res 57:374-383, 2001.
46. King, A., Sandler, S., Andersson, A., Hellerstrom, C., Kulseng, B. & Skjak-Braek, G.: Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field: Diabetes Care 22 Suppl 2:B121-B126, 1999.
47. Kishida, A., Kato, S., Ohmura, K., Sugimura, K. & Akashi, M.: Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis. I. Study of IL-1 beta mRNA expression: Biomaterials 17:1301-1305, 1996.
48. Kubes, P., Suzuki, M. & Granger, D.N.: Nitric oxide: an endogenous modulator of leukocyte adhesion: Proc Natl Acad Sci U S A 88:4651-4655, 1991.
49. Kulseng, B., Thu, B., Espevik, T. & Skjak-Braek, G.: Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane: Cell Transplant 6:387-394, 1997.
50. Landgraf, R.: Impact of pancreas transplantation on diabetic secondary complications and quality of life: Diabetologia 39:1415-1424, 1996.
51. Lanza, R. P., Sullivan, S. J. & Chick, W. L.: Perspectives in diabetes. Islet transplantation with immunoisolation: Diabetes 41:1503-1510, 1992.
52. Leblond, F. A., Simard, G., Henley, N., Rocheleau, B., Huet, P. M. & Halle, J. P.: Studies on smaller (approximately 315 microM) microcapsules: IV. Feasibility and safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules: Cell Transplant 8:327-337, 1999.
53. Legallais, C. & Doré, D. E.: Bioartificial livers (BAL): current technological aspects and future developments: J Membrane Sci 181:81-95, 2001.
54. Li, R. H.: Materials for immunoisolated cell transplantation: Adv Drug Deliv Rev 33:87-109, 1998.
55. Lim, F. & Sun, A. M.: Microencapsulated islets as bioartificial endocrine pancreas: Science 210:908-910, 1980.
56. Maki, T., Otsu, I., O'Neil, J. J., Dunleavy, K., Mullon, C. J., Solomon, B. A. & Monaco, A. P.: Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas: Diabetes 45:342-347, 1996.
57. Mandrup-Poulsen, T.: The role of interleukin-1 in the pathogenesis of IDDM: Diabetologia 39:1005-1029, 1996.
58. Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A. & Nerup, J.: Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity: J Immunol 139:4077-4082, 1987.
59. Mashimo, H. & Goyal, R. K.: Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice: Am J Physiol 277:G745-G750, 1999.
60. Moe, S., Draget, K., Skjåk-Braek, G. & Smidsrod, O.: Alginates: 245-286, 1995.
61. Moilanen, E., Moilanen, T., Knowles, R., Charles, I., Kadoya, Y., al Saffar, N., Revell, P. A. & Moncada, S.: Nitric oxide synthase is expressed in human macrophages during foreign body inflammation: Am J Pathol 150:881-887, 1997.
62. Mor, E., Yussim, A., Chodoff, L. & Schwartz, M. E.: New immunosuppressive agents for maintenance therapy in organ transplantation. Focus on adverse effects: Biodrugs 8:469-488, 1997.
63. Mullen, Y., Maruyama, M. & Smith, C. V.: Current progress and perspectives in immunoisolated islet transplantation: J Hepatobiliary Pancreat Surg 7:347-357, 2000.
64. Newsholme, P., Gordon, S. & Newsholme, E. A.: Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages: Biochem J 242:631-636, 1987.
65. Noth, U., Grohn, P., Jork, A., Zimmermann, U., Haase, A. & Lutz, J.: 19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues: Magn Reson Med 42:1039-1047, 1999.
66. O'Shea, G. M. & Sun, A. M.: Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice: Diabetes 35:943-946, 1986.
67. Panza, J. L., Wagner, W. R., Rilo, H. L., Rao, R. H., Beckman, E. J. & Russell, A. J.: Treatment of rat pancreatic islets with reactive PEG: Biomaterials 21:1155-1164, 2000.
68. Penn, I.: Post-transplant malignancy: the role of immunosuppression: Drug Saf 23:101-113, 2000.
69. Pueyo, M. E., Darquy, S., Capron, F. & Reach, G.: In vitro activation of human macrophages by alginate-polylysine microcapsules: J Biomater Sci Polym Ed 5:197-203, 1993.
70. Ramchand, C. N., Gliddon, A. E., Clark, A. E. & Hemmings, G. P.: Glucose oxidation and monoamine oxidase activity from the fibroblasts of schizophrenic patients and controls: Life Sci 56:1639-1646, 1995.
71. Rihova, B.: Immunocompatibility and biocompatibility of cell delivery systems: Adv Drug Deliv Rev 42:65-80, 2000.
72. Ryan, E. A., Lakey, J. R., Rajotte, R. V., Korbutt, G. S., Kin, T., Imes, S., Rabinovitch, A., Elliott, J. F., Bigam, D., Kneteman, N. M., Warnock, G. L., Larsen, I. & Shapiro, A. M.: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol: Diabetes 50:710-719, 2001.
73. Sabatine, M. S., Laufer, T., Glimcher, L. H., Widmer, M., Winn, H. & Auchincloss, H., Jr.: Delayed rejection of soluble tumor necrosis factor receptor-secreting tumor allografts: Transplantation 65:113-120, 1998.
74. Sandberg, J. O., Eizirik, D.L., Sandler, S., Tracey, D.E. & Andersson, A.: Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival: Diabetes 42:1845-1851, 1993.
75. Sandler, S., Andersson, A., Eizirik, D. L., Hellerstrom, C., Espevik, T., Kulseng, B., Thu, B., Pipeleers, D. G. & Skjak-Braek, G.: Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters and rat, mouse, and human pancreatic islets: Transplantation 63:1712-1718, 1997.
76. Sandler, S., Eizirik, D. L., Svensson, C., Strandell, E., Welsh, M. & Welsh, N.: Biochemical and molecular actions of interleukin-1 on pancreatic b-cells: Autoimmunity 10:241-253, 1991.
77. Shapiro, A. M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M. & Rajotte, R. V.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppessive regimen: N Engl J Med 343:230-238, 2000.
78. Siebers, U., Horcher, A., Brandhorst, H., Brandhorst, D., Hering, B., Federlin, K., Bretzel, R. G. & Zekorn, T.: Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation: J Mol Med 77:215-218, 1999.
79. Siebers, U., Horcher, A., Bretzel, R. G., Klock, G., Zimmermann, U., Federlin, K. & Zekorn, T.: Transplantation of free and microencapsulated islets in rats: evidence for the requirement of an increased islet mass for transplantation into the peritoneal site: Int J Artif Organs 16:96-99, 1993.
80. Smith, R. A. & Baglioni, C.: The active form of tumor necrosis factor is a trimer: J Biol Chem 262:6951-6954, 1987.
81. Soon-Shiong, P., Otterlie, M., Skjak-Braek, G., Smidsrod, O., Heintz, R., Lanza, R. P. & Espevik, T.: An immunologic basis for the fibrotic reaction to implanted microcapsules: Transplant Proc 23:758-759, 1991.
82. Southern, C., Schulster, D. & Green, I. C.: Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism: FEBS Lett 276:42-44, 1990.
83. Spector, M., Cease, C. & Tong-Li, X.: The local tissue response to biomaterials: Critical Reviews in Biocompatibility 5:269-295, 1989.
84. Strand, B. L., Mörch, Y. A. & Skjåk-Braek, G.: Alginate as immbolization matrix for cells: Minerva biotecnologica 12:223-233, 2001.
85. Strand, B. L., Ryan, L., In't Veld, P., Kulseng B., Rokstad, A. M., Skjåk-Braek, G. & Espevik, T.: Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines: Cell Transplantation 10:263-275, 2001.
86. Sutherland, D. E., Gruessner, R. W. & Gruessner, A. C.: Pancreas transplantation for treatment of diabetes mellitus: World J Surg 25:487-496, 2001.
87. Suzuki, K., Bonner-Weir, S., Hollister-Lock, J., Colton, C. K. & Weir, G. C.: Number and volume of islets transplanted in immunobarrier devices: Cell Transplant 7:47-52, 1998.
88. Suzuki, K., Bonner-Weir, S., Trivedi, N., Yoon, K. H., Hollister-Lock, J., Colton, C. K. & Weir, G. C.: Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice: Transplantation 66:21-28, 1998.
89. Tai, I., Vacek, I. & Sun, A.: The alginate-poly-L-lysine-alginate membrane: Evidence of a protective effect on microencapsulated islets of Langerhans following exposure to cytokines: Xenotransplantation 2:37-45, 1995.
90. Tang, L. & Eaton, J. W.: Natural responses to unnatural materials: A molecular mechanism for foreign body reactions: Mol Med 5:351-358, 1999.
91. Tatarkiewicz, K., Garcia, M., Omer, A., Van Schilfgaarde, R., Weir, G. C. & De Vos, P.: C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets: Diabetologia 44:646-653, 2001.
92. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.: N Engl J Med 329:977-986, 1993.
93. Theodorou, N. A., Vrbova, H., Tyhurst, M. & Howell, S. L.: Problems in the use of polycarbonate diffusion chambers for syngeneic pancreatic islet transplantation in rats: Diabetologia 18:313-317, 1980.
94. Thomas, A., Harding, K. G. & Moore, K.: Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-alpha: Biomaterials 21:1797-1802, 2000.
95. Udelsman, R., Boyne, M.S., Loman, K. E. & Saudek, C. D.: Intraperitoneal delivery of insulin via mechanical pump: surgical implications: Langenbecks Arch Surg 385:367-372, 2000.
96. Uludag, H., De Vos, P. & Tresco, P. A.: Technology of mammalian cell encapsulation: Adv Drug Deliv Rev 42:29-64, 2000.
97. Van Schilfgaarde, R. & De Vos, P.: Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets: J Mol Med 77:199-205, 1999.
98. Vandenbossche, G. M., Bracke, M. E., Cuvelier, C. A., Bortier, H. E., Mareel, M. M. & Remon, J. P.: Host reaction against alginate-polylysine microcapsules containing living cells: J Pharm Pharmacol 45:121-125, 1993.
99. Vandenbossche, G. M., Bracke, M. E., Cuvelier, C. A., Bortier, H. E., Mareel, M. M. & Remon, J. P.: Host reaction against empty alginate-polylysine microcapsules. Influence of preparation procedure: J Pharm Pharmacol 45:115-120, 1993.
100. Welsh, M., Welsh, N., Bendtzen, K., Mares, J., Strandell, E., Oberg, C. & Sandler, S.: Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice: Diabetologia 38:153-160, 1995.
101. Wiegand, F., Kroncke, K. D. & Kolb-Bachofen, V.: Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes: Transplantation 56:1206-1212, 1993.
102. Wijsman, J., Atkison, P., Mazaheri, R., Garcia, B., Paul, T., Vose, J., O'Shea, G. & Stiller, C.: Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/W rats: Transplantation 54:588-592, 1992.
103. Winn, S. R., Tresco, P. A., Zielinski, B., Greene, L. A., Jaeger, C. B. & Aebischer, P.: Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells: Exp Neurol 113:322-329, 1991.
104. Zekorn, T., Endl, U., Horcher, A., Siebers, U., Bretzel, B. & Federlin, K.: Evidence for an antigen-release induced cellular immune response against alginate-polylysine encapsulated islets: Xenotransplantation 2:116-119, 1995.